Private equity firms reportedly offer $16B-plus to acquire Hologic

Private equity firms TPG and Blackstone purportedly offered $16 billion-plus in a bid to acquire Hologic and take the publicly traded imaging vendor private, according to a report published Tuesday. 

The Financial Times first shared news of the deal, citing anonymous sources familiar with the conversations. Hologic reportedly rejected the offer in recent weeks, which would have valued the Marlborough, Massachusetts-based company at between $16.3 billion to $16.7 billion including debt. 

Despite the decision, the parties still left the door open for continued negotiations. These conversations come as Hologic has faced challenges in recent months, including a drop in sales of its mammography systems and projected impacts from tariffs. 

Hologic did not respond to the Financial Times’ requests for a statement, while TPG and Blackstone declined comment. The two PE firms are “serial investors” in healthcare, the FT noted, last year teaming on a takeover bid for eyecare company Bausch + Lomb before talks eventually fell through. 

Read more here:

Marty Stempniak

Marty Stempniak has covered healthcare since 2012, with his byline appearing in the American Hospital Association's member magazine, Modern Healthcare and McKnight's. Prior to that, he wrote about village government and local business for his hometown newspaper in Oak Park, Illinois. He won a Peter Lisagor and Gold EXCEL awards in 2017 for his coverage of the opioid epidemic. 

Around the web

The new F-18 flurpiridaz radiotracer is expected to help drive cardiac PET growth, but it requires waiting between rest and stress scans. Software from MultiFunctional Imaging can help care teams combat that problem.

News of an incident is a stark reminder that healthcare workers and patients aren’t the only ones who need to be aware around MRI suites.

The ACR hopes these changes, including the addition of diagnostic performance feedback, will help reduce the number of patients with incidental nodules lost to follow-up each year.